Dr.T, highly appreciate your views which makes complete sense. Can I get your views on what you think of probability of clinical success of each pillar and Revenue/ NPAT by pillar?
Personally, I am uncomfortable with excess of 33% (1 out of 3) chance of clinical trial success to keep my feet firmly on the ground. Happier to err on the side of caution. (Context: Been burned with Mesoblast after FDA didn’t approve despite their advisory committee overwhelmingly voting in favour of the aGVHD drug).
RAC Price at posting:
$1.72 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)